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Lanthanoid ions exhibit extremely large anomalous X-ray scattering at their
LIII absorption edge. They are thus well suited for anomalous diffraction
experiments. A novel class of lanthanoid complexes has been developed that
combines the physical properties of lanthanoid atoms with functional chemical
groups that allow non-covalent binding to proteins. Two structures of large
multimeric proteins have already been determined by using such complexes.
Here the use of the luminescent europium tris-dipicolinate complex
[Eu(DPA)3]
3  to solve the low-resolution structure of a 444 kDa homo-
dodecameric aminopeptidase, called PhTET1-12s from the archaea Pyrococcus
horikoshii, is reported. Surprisingly, considering the low resolution of the data,
the experimental electron density map is very well deﬁned. Experimental phases
obtained by using the lanthanoid complex lead to maps displaying particular
structural features usually observed in higher-resolution maps. Such complexes
open a new way for solving the structure of large molecular assemblies, even
with low-resolution data.
Keywords: lanthanoid complexes; experimental phasing; large macromolecular assemblies;
TET aminopeptidase.
1. Introduction
Even though most of the newly deposited structures in the
Protein Data Bank (PDB) were solved by molecular repla-
cement, experimental phasing remains essential for deter-
mining three-dimensional protein structures if only for solving
structures with new folds or which signiﬁcantly differ from
any known model structure. Over the last ten years, methods
based on anomalous scattering, namely the single-wavelength
anomalous diffraction (SAD) and multiple-wavelength
anomalous diffraction (MAD) methods, have replaced the
traditional methods based on isomorphous replacement, thus
becoming the methods of choice for solving de novo protein
structures. Consequently, the preparation of effective heavy-
atom derivatives displaying anomalous scattering has become
a key point for de novo crystal structure determination. With
the incorporation of selenium through the substitution of
methionine residues by seleno-methionine (Hendrickson et
al., 1990; Doublie, 1997), and with the developments at third-
generation synchrotron radiation sources, which allow weak
anomalous signals from intrinsic scatterers to be used, the
time-consuming preparation of heavy-atom derivatives has
been facilitated.
However, the use of such procedures is not always possible,
which revives the problem of incorporating effective anom-
alous scatterers into protein crystals. Therefore, we proposed
to use lanthanoid complexes for preparing lanthanoid deri-
vative crystals (Girard et al., 2002). Lanthanoid ions, Ln
3+, are
well suited to anomalous diffraction experiments since they all
exhibit a strong white line in their LIII absorption edge leading
to extremely large anomalous contributions of almost 30 e
 
for both f 0 and f 00.
A way to assess the phasing power of lanthanides is to
compare them with the most frequently used anomalous
scatterer, i.e. selenium from seleno-methionine. For this
purpose the Bijvoet ratio can be considered. We have shown
(Girard, Stelter et al., 2003) that the Bijvoet ratio can be
expressed as
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where NP is the number of atoms of the protein of mean
scattering factor Zeff, qj and f 00
j are the site occupancy and theimaginary part of the atomic scattering factor of the anom-
alous scatterer j, respectively. This formula clearly shows that,
assuming ﬁxed site occupancies, identical Bijvoet ratios are
obtained for a protein that is four times larger when f 00
j is
doubled for each anomalous scatterer. Assuming that the
diffraction data are collected at the respective absorption
edge, f 00
j values are about 10 and 30 e
  for selenium and
lanthanoid, respectively. This means that one fully occupied
lanthanoid atom will allow a protein that is nine times larger,
compared with a fully occupied Se atom, to be phased.
Hence, lanthanoids are good candidates for macro-
molecular structure determination based on the use of the
anomalous signal. Lanthanoid ions were used in early MAD
studies on calcium-binding proteins (Kahn et al., 1985; Weis
et al., 1991) as they can substitute for Ca
2+. Nagem et al.
(2001) proposed to incorporate lanthanoid salts through the
quick cryo-soak method, but soaking crystals in solutions
containing lanthanoid salts often damages the crystals owing
to the preferred nine-based coordination of lanthanoid ions.
To overcome this problem, Purdy et al. (2002) proposed
to use a covalent linkage between a lanthanoid complex
featuring a saturated coordination sphere and the protein of
interest through a thio-reactive functionality, and Silvaggi
et al. (2007) proposed to use a double lanthanoid-binding
tag.
Girard et al. (2002) proposed to use gadolinium complexes
initially used as contrast agents for magnetic resonant imaging
to incorporate lanthanoid ions into protein crystals. Seven
different gadolinium complexes were studied (Girard, Stelter
et al., 2003). These complexes are made of a ligand that
surrounds the lanthanoid ions as a cage, thus providing the
majority of the coordination sphere of the ion. More recently,
we have proposed to use complexes based on dipicolinate
(DPA = pyridine-2,6-dicarboxylate) ligands, namely the
lanthanoid tris-dipicolinate complex ions [Ln(DPA)3]
3 , the
Eu and Tb complexes being luminescent (D’Ale ´o et al., 2007;
Pompidor et al., 2008). As previously mentioned, lanthanoid
salts often damage protein crystals even at low concentration.
The great advantage of using lanthanoid complexes comes
from the fact that the interaction of the lanthanoid ions with
the protein occurs through the ligand forming the complexes
rather than direct interaction. The binding mode of the
various used complexes to the protein turned out to depend
on the nature of the ligand (Girard, Anelli et al., 2003). These
complexes can be introduced in protein crystals either by co-
crystallization or soaking and can be used at rather high
concentration (50 to 100 mM).
The technique of introducing lanthanoid ions into protein
crystals by using lanthanoid complexes
1 was successfully used
to solve the structure of several proteins (Chaudhuri et al.,
2003; de Bono et al., 2005; Hermoso et al., 2005; Jeudy et al.,
2005; Ma ´rquez et al., 2006; Gras et al., 2007; Delfosse et al.,
2009; Molina et al., 2009; Arnoux et al., 2009; Pe ´rez-Dorado,
Gonza ´lez et al., 2010; Pe ´rez-Dorado, Sanles et al., 2010).
The lanthanoid complexes have also been used to solve
structures of large macromolecular assemblies. The structure
of a chimeric ornithine carbamoyl transferase, OTCase3630, a
dodecamer of 450 kDa, was solved by using the SAD method
(Girard, Stelter et al., 2003). More recently, the structure of the
Pyrococcus abyssi Pab87 protein, an archaeal member of a
new self-compartmentalizing protease family forming a cubic-
shaped octamer of 400 kDa, was determined at 2.2 A ˚ resolu-
tion by the SAD method (Delfosse et al., 2009).
Here, we report the use of the tris-dipicolinate complex to
obtain experimental phases at low resolution on a large homo-
dodecameric enzyme, PhTET1-12s, which is a tetrahedral
aminopeptidase belonging to a new family of self-compart-
mentalized large protease complexes (Franzetti et al., 2002).
The TET peptidase was initially isolated from Haloarcula
marismortui (Franzetti et al., 2002). In the archae Pyrococcus
horikoshii, three different open reading frames coding for
TET-homologous proteins were identiﬁed. These were named
PhTET1, 2 and 3. Their three-dimensional structures were
determined (Franzetti et al., 2002; Russo & Baumann, 2004;
Borissenko & Groll, 2005; Schoehn et al., 2006; Dura ´ et al.,
2009). It has been shown (Schoehn et al., 2006) that PhTET1
assembles as a tetrahedral dodecameric particle (called
PhTET1-12s for the 444 kDa assembly made up of 12 sub-
units) or as an octahedral tetracosameric ediﬁce (called
PhTET1-24s for the 888 kDa assembly made up of 24 sub-
units).
Since the TET particles are highly symmetrical molecular
ediﬁces formed by a single type of subunit, they provide an
excellent model for probing the phasing capacity of different
lanthanoid complexes. Moreover, the currently available TET
crystallographic structures do not permit detailed analyses
of the particles interior. The polypeptide trafﬁcking and the
processing mechanisms by the TET particles remain therefore
unclear. In this paper we show that low-resolution experi-
mental phase obtained with tris-dipicolinate complex can
provide novel structural information on the PhTET1-12s
complex.
2. Materials and methods
2.1. Materials
The expression of TET1-12s from P. horikoshii in Escher-
ichia coli, its puriﬁcation and initial crystallization assays
will be described elsewhere (Dura et al., 2010). Na3[Eu-
(DPA)3].6H2O complex where DPA stands for pyridine-2,6-
dicarboxylate (e.g. dipicolinate) was prepared using the
procedure described by Tancrez et al. (2005).
2.2. Crystallization
Crystallization was performed by vapour diffusion using the
hanging-drop method at 293 K. Native PhTET1-12s crystals
( 200 mm   140 mm   20 mm) were grown within three weeks
by mixing 1.5 ml of 6.2 mg ml
 1 protein solution and 1.5 mlo f
20–22% PEG 3350 (or 20% PEG 2000 MME), 100 mM Tris-
HCl buffer at pH 7.5 and 200 mM trimethylamine N-oxide
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1 The different lanthanoid complexes can be purchased from NatX-ray (http://
www.natx-ray.com/home.html).reservoir solution. PhTET1-12s derivative crystals ( 150 mm
  150 mm   30 mm) were obtained within three weeks by
cocrystallization with [Eu(DPA)3]
3  by mixing 1.5 mlo f6 . 2m g
ml
 1 protein solution, 1.5 ml of 220 mM Na3[Eu(DPA)3].6H2O
solution and 1.5 ml of reservoir solution containing 23–24%
PEG 3350 (or 23–26% PEG 2000 MME).
Prior to data collection, derivative crystals were cryo-cooled
in liquid nitrogen using mother liquor containing 20% ethyl-
ene glycol as cryo-protectant.
2.3. Data collection and data processing
SAD data were collected on the FIP-BM30A beamline at
the ESRF. Based on a ﬂuorescence scan, the wavelength was
chosen at the LIII europium absorption edge, and was set to
1.766 A ˚ , which corresponds to the maximum value of f 00
( 28 e
 ). Diffraction data were integrated using the program
XDS (Kabsch, 2010a,b) and the integrated intensities were
scaled and merged using the CCP4 programs SCALA and
TRUNCATE (Collaborative Computa-
tional Project, Number 4, 1994). A
summary of the processing statistics is
given in Table 1.
3. Results
3.1. Derivative crystal form
As described in x2, we used crystal-
lization conditions that led to a new
high-resolution form of PhTET1-12s in
space group P21 with an entire dode-
camer in the asymmetric unit (Dura et
al., 2010). Surprisingly, the addition of
the tris-dipicolinate complex led to the
initial F4132 crystal form diffracting
at low resolution, that was used for
the initial structure determination
of PhTET1-12s at 3.09 A ˚ resolution
(Porciero et al., 2005; Schoehn et al.,
2006).
3.2. De novo structure determination
As shown in Table 1, the high value of Rano clearly indicated
the presence of tris-dipicolinate europium complex binding
sites, which was then conﬁrmed by the anomalous Patterson
map. Despite the low resolution of the data, we attempted
de novo phasing of the structure of PhTET1-12s. Using the
program SHELXD (Sheldrick, 2008), we were able to locate
one Eu site per TET-monomer. Heavy-atom reﬁnement and
initial phasing were performed using the program SHARP
(La Fortelle & Bricogne, 1997). Phases from SHARP were
improved by density modiﬁcation using the CCP4 program
DM (Cowtan & Main, 1996) assuming a solvent content
of 50%.
3.3. Experimental 4.0 A ˚ SAD phasing
Despite the low resolution, the experimental phases were
accurate since the ﬁgure of merit after SHARP and DM are
0.369 and 0.731, respectively. The resulting experimental
electron density map was of good quality (Fig. 1a) since it
allowed the polypeptide chain to be traced, as shown in
Fig. 2(a). The overall shape of the PhTET1-12 subunit particle
could be easily recognized with, on one side of the particle, the
large channel (Fig. 1b) assumed to be the entrance for the
peptide substrate and, on the other side, the small channel
(Fig. 1c) assumed to be the exit pathway for the reaction
products, which are individual amino acids.
3.4. Experimental 3.09 A ˚ SIRAS phasing
We performed SIRAS (single isomorphous replacement
with anomalous scattering) phasing using the 3.09 A ˚ resolu-
tion native data set from which the structure of PhTET1-12s
(PDB code 2cf4) was solved by molecular replacement
(Rossmann, 1990). As for the SAD phasing, the SIRAS
experimental phases were accurate since the ﬁgure of merit
diffraction structural biology
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Table 1
Data collection and processing statistics of the [Eu(DPA)3]
3  derivative
of TET1-12s.
Space group F4132
Unit-cell parameter a 219.83 A ˚
Resolution range (high-resolution shell) 49.16–4.00 A ˚ (4.22–4.00 A ˚ )
No. of unique reﬂections 4207 (591)
Rmerge† 8.6% (22.3%)
Rpim‡ 3.0% (8.7%)
Rano§ 6.8% (7.8%)
I/ (I)} 7.5 (3.5)
Completeness 99.9% (97.9%)
Multiplicity 13.7 (13.7)
† Rmerge ¼
P
h
P
i  I IðhÞ IiðhÞ
       =
P
h
P
i IiðhÞ
        where IiðhÞ is the ith measurement
of reﬂection h and  I IðhÞ is the mean measurement of reﬂection
h.‡ Rpim ¼
P
h ½1=ðN   1Þ 
1=2 P
i IiðhÞ  I IðhÞ
       =
P
h
P
i IiðhÞ. This indicator, which
describes the precision of the averaged measurement, is most relevant (Weiss,
2001). § Rano ¼
P
h  I IþðhÞ  I I ðhÞ
       =
P
h  I IþðhÞþ I I ðhÞ
        where  I IþðhÞ and  I I ðhÞ are
the mean intensities of a Friedel mate. } I/ (I) is the signal-to-noise ratio for merged
intensities.
Figure 1
(a) Experimental 4.0 A ˚ SAD electron density map contoured at 1.5  showing (b) one of the large
pores situated in each facet of the PhTET1-12s particle that gives access to the interior of the system
and (c) one of the small oriﬁces situated on each of the four apices. Figs.1 and 2 were prepared using
COOT (Emsley et al., 2010) and PyMOL (http://www.pymol.org/).after SHARP and DM were 0.211 and 0.785, respectively.
Despite the introduction of the tris-dipicolinate europium
complex, the isomorphism between the native and derivative
crystals was preserved. The resulting SIRAS electron density
map was of high quality, as shown in Fig. 2(b).
4. Conclusion
We have shown that, using [Eu(DPA)3]
3 , the high-phasing-
power heavy-atom derivative of PhTET1-12s may be
obtained by co-crystallization. Highly accurate experimental
phases were obtained, even at the low resolution of this work
(4.0 A ˚ ). The presence of the [Eu(DPA)3]
3  complex modiﬁed
the crystal space group: from crystallization conditions that
led to the monoclinic crystal form diffracting at high reso-
lution, the introduction of [Eu(DPA)3]
3  induced the
formation of cubic crystals. Pompidor et al. (2010) showed
that the interaction between the protein and the
[Ln(DPA)3]
3  complex occurs through hydrogen bonds
between the O atom of the carboxylate groups of the DPA
ligands and hydrogen-bond donor residues, and through
hydrophobic  -stacking interaction between DPA rings and
aromatic residues. In some cases this speciﬁc binding mode
improves the protein–protein interaction involved in crystal
packing leading to supramolecular interactions. In the
present structure it seems that it is not the case. Even if the
low resolution of the data limits the modelling of the DPA
ligand, the Eu
3+ ion is located between two monomers on the
large channel side of the particle, as shown in Fig. 2(c). These
two monomers are supposed to be the minimal building block
of the whole particle. Since the [Eu(DPA)3]
3  complex is
bound within this building block, it did not directly inﬂuence
the molecular packing as would be the case if bridging two
building blocks. A possible explanation for the space group
change is that binding of the tris-dipicolinate europium
complex induces a small conformational change in the
PhTET1-12s protomer, leading to the growth of the low-
resolution crystal form.
The tris-dipicolinate europium complex binding site is
l o c a t e di nt h ev i c i n i t yo fal o o p ,w h i c hi sa s s u m e dt ob eak e y
player in the addressing of the substrate toward the catalytic
chambers of the TET particle (Dura ´ et al., 2009). To obtain
new insights into this important functional zone, we
therefore plan to attempt to increase the resolution of
the experimental data either by soaking PhTET1 crystals
in solutions containing [Eu(DPA)3]
3  or by preparing
[Eu(DPA)3]
3  derivative crystals of PhTET2 or PhTET3, in
order to obtain more precise experimental (i.e. model-bias
free) information.
As mentioned, the binding of the lanthanoid complexes to
the protein depends on their ligand, the non-covalent inter-
action being for example hydrophobic (for the complex Gd-
HPDO3A; Girard, Stelter et al., 2003) or through hydrogen
bonding between arginine/lysine residues and the dipicolinate
complex (Pompidor et al., 2010). Thus, the probability of
occurrence of the appropriate binding sites in the protein
increases with the protein size. Combined with the strong
anomalous signal of the lanthanoid ions, these complexes are
thus efﬁcient tools for solving the structure of large macro-
molecular assemblies, irrespective of their size.
This work was supported by the French National Research
Agency (ANR Project MacroTET; BLAN07-3_204002).
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Figure 2
(a) Experimental 4.0 A ˚ SAD electron density map. (b) Experimental
3.09 A ˚ SIRAS electron density map. Both maps are contoured at 1.5 .
The model shown corresponds to PDB code 2cf4 (Schoehn et al., 2006).
(c) Anomalous Fourier map contoured at 10  showing that the Eu
3+ ion
of the [Eu(DPA)3]
3  complex is located between two monomers on the
large channel side of the particle. This dimer is considered as the minimal
building block to form the whole TET1 particle.References
Arnoux, P., Morosinotto, T., Saga, G., Bassi, R. & Pignol, D. (2009).
Plant Cell, 21, 2036–2044.
Bono, S. de, Riechmann, L., Girard, E., Williams, R. L. & Winter, G.
(2005). Proc. Natl. Acad. Sci. USA, 102, 1396–1401.
Borissenko, L. & Groll, M. (2005). J. Mol. Biol. 346, 1207–1219.
Chaudhuri, B. N., Sawaya, M. R., Kim, C. Y., Waldo, G. S., Park, M. S.,
Terwilliger, T. C. & Yeates, T. O. (2003). Structure, 11, 753–764.
Collaborative Computational Project, Number 4 (1994). Acta Cryst.
D50, 760–763.
Cowtan, K. D. & Main, P. (1996). Acta Cryst. D52, 43–48.
D’Ale ´o, A., Pompidor, G., Elena, B., Vicat, J., Baldeck, P. L., Toupet,
L., Kahn, R., Andraud, C. & Maury, O. (2007). ChemPhysChem, 8,
2125–2132.
Delfosse, V., Girard, E., Birck, C., Delmarcelle, M., Delarue, M.,
Poch, O., Schultz, P. & Mayer, C. (2009). PLoS ONE, 4, e4712.
Doublie, S. (1997). Methods Enzymol. 276, 523.
Dura ´,M .A .et al. (2010). In preparation.
Dura ´, M. A., Rosenbaum, E., Larabi, A., Gabel, F., Vellieux, F. M. D.
& Franzetti, B. (2009). Mol. Microbiol. 72, 26–40.
Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. (2010). Acta
Cryst. D66, 486–501.
Franzetti, B., Schoehn, G., Hernandez, J.-F., Jaquinod, M., Ruigrok,
R. W. H. & Zaccai, G. (2002). EMBO J. 21, 2132–2138.
Girard, E ´ ., Anelli, P. L., Vicat, J. & Kahn, R. (2003). Acta Cryst. D59,
1877–1880.
Girard, E ´., Chantalat, L., Vicat, J. & Kahn, R. (2002). Acta Cryst. D58,
1–9.
Girard, E ´., Stelter, M., Vicat, J. & Kahn, R. (2003). Acta Cryst. D59,
1914–1922.
Gras, S., Chaumont, V., Fernandez, B., Carpentier, P., Charrier-
Savournin, F., Schmitt, S., Pineau, C., Flament, D., Hecker, A.,
Forterre, P., Armengaud, J. & Housset, D. (2007). EMBO Rep. 8,
569–575.
Hendrickson, W. A., Horton, J. R. & Lemaster, D. M. (1990). EMBO
J. 9, 1665–1672.
Hermoso, J. A., Lagartera, L., Gonza ´lez, A., Stelter, M., Garcı ´a, P.,
Martı ´nez-Ripoll, M., Garcı ´a, J. L. & Mene ´ndez, M. (2005). Nat.
Struct. Mol. Biol. 12, 533–538.
Jeudy, S., Stelter, M., Coutard, B., Kahn, R. & Abergel, C. (2005).
Acta Cryst. F61, 848–851.
Kabsch, W. (2010a). Acta Cryst. D66, 125–132.
Kabsch, W. (2010b). Acta Cryst. D66, 133–144.
Kahn, R., Fourme, R., Bosshard, R., Chiadmi, M., Risler,J., Dideberg,
O. & Wery, J. (1985). FEBS Lett. 179, 133–137.
La Fortelle, E. de & Bricogne, G. (1997). Methods Enzymol. 276, 472–
494.
Ma ´rquez, J., Reinelt, S., Koch, B., Engelmann, R., Hengstenberg, W.
& Scheffzek, K. (2006). J. Biol. Chem. 281, 32508–32515.
Molina, R., Gonza ´lez, A., Stelter, M., Pe ´rez-Dorado, I., Kahn, R.,
Morales, M., Moscoso, M., Campuzano, S., Campillo, N. E.,
Mobashery, S., Garcı ´a, J. L., Garcı ´a, P. & Hermoso, J. A. (2009).
EMBO Rep. 10, 246–251.
Nagem, R. A. P., Dauter, Z. & Polikarpov, I. (2001). Acta Cryst. D57,
996–1002.
Pe ´rez-Dorado, I., Gonza ´lez, A., Morales, M., Sanles, R., Striker, W.,
Vollmer, W., Mobashery, S., Garcı ´a, J. L., Martı ´nez-Ripoll, M.,
Garcı ´a, P. & Hermoso, J. A. (2010). Nat. Struct. Mol. Biol. 17, 576–
581.
Pe ´rez-Dorado, I., Sanles, R., Gonza ´lez, A., Garcı ´a, P., Garcı ´a, J. L.,
Martı ´nez-Ripoll, M. & Hermoso, J. A. (2010). Acta Cryst. F66, 448–
451.
Pompidor, G., D’Ale ´o, A., Vicat, J., Toupet, L., Giraud, N., Kahn, R.
& Maury, O. (2008). Angew. Chem. Int. Ed. 47, 3388–3391.
Pompidor, G., Maury, O., Vicat, J. & Kahn, R. (2010). Acta Cryst. D66,
762–769.
Porciero, S., Receveur-Bre ´chot, V., Mori, K., Franzetti, B. & Roussel,
A. (2005). Acta Cryst. F61, 239–242.
Purdy, M. D., Ge, P., Chen, J., Selvin, P. R. & Wiener, M. C. (2002).
Acta Cryst. D58, 1111–1117.
Rossmann, M. G. (1990). Acta Cryst. A46, 73–82.
Russo, S. & Baumann, U. (2004). J. Biol. Chem. 279, 51275–51281.
Schoehn, G., Vellieux, F. M. D., Asuncio ´n Dura ´, M., Receveur-
Bre ´chot, V.,Fabry, C. M.S., Ruigrok, R.W. H., Ebel, C., Roussel, A.
& Franzetti, B. (2006). J. Biol. Chem. 281, 36327–36337.
Sheldrick, G. M. (2008). Acta Cryst. A64, 112–122.
Silvaggi, N. R., Martin, L. J., Schwalbe, H., Imperiali, B. & Allen, K. N.
(2007). J. Am. Chem. Soc. 129, 7114–7120.
Tancrez, N., Feuvrie, C., Ledoux, I., Zyss, J., Toupet, L., Le Bozec, H.
& Maury, O. (2005). J. Am. Chem. Soc. 127, 13474–13475.
Weis, W. I., Kahn, R., Fourme, R., Drickamer, K. & Hendrickson,
W. A. (1991). Science, 254, 1608–1615.
Weiss, M. S. (2001). J. Appl. Cryst. 34, 130–135.
diffraction structural biology
78 Romain Talon et al.   Lanthanoid complexes J. Synchrotron Rad. (2011). 18, 74–78